NCT04827459 is a NA clinical trial of Sleep Coach App in Insomnia, sponsored by University of Michigan Rogel Cancer Center.

Who is sponsoring NCT04827459?

NCT04827459 is sponsored by University of Michigan Rogel Cancer Center.

What drugs are being tested in NCT04827459?

Interventions in NCT04827459: Sleep Coach App.

What condition does NCT04827459 study?

NCT04827459 studies Insomnia, Breast Cancer, Prostate Cancer, Colon Cancer.

Is NCT04827459 still recruiting?

NCT04827459 is currently completed. Last updated 2 November 2022.

Last reviewed 2022-11-02 · How we verify

NCT04827459

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors

Completed NA Last updated 2 November 2022

What this trial tests

NA trial testing Sleep Coach App in Insomnia in 30 participants. Completed in 8 August 2022.

Timeline

12 May 2021

Primary endpoint
8 August 2022

8 August 2022

Quick facts

Lead sponsor	University of Michigan Rogel Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	30
Start date	12 May 2021
Primary completion	8 August 2022
Estimated completion	8 August 2022
Sites	1 location across United States

Drugs / interventions tested

Sleep Coach App

Conditions studied

Insomnia — all drugs for Insomnia →
Breast Cancer — all drugs for Breast Cancer →
Prostate Cancer — all drugs for Prostate Cancer →
Colon Cancer — all drugs for Colon Cancer →

Sponsor

University of Michigan Rogel Cancer Center

Who can join

18 and older, any sex, with Insomnia or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial will evaluate the adherence, usefulness, satisfaction and effect size for the Sleep Coach app as an intervention for insomnia in 30 adult post-treatment cancer survivors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mi Sleep Coach Mobile App to Address Insomnia Symptoms Among Cancer Survivors: Single-Arm Feasibility Study.
Arring N, Barton DL, Lafferty C, Cox B, et al · · 2024 · cited 1× · PMID 38669678 · DOI 10.2196/55402

Verify or expand the search:

Other recruiting trials for Insomnia

Currently open trials in the same condition.

NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting

Other University of Michigan Rogel Cancer Center trials

Trials by the same sponsor.

NCT06914479 — Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and · Phase 1 · recruiting
NCT07481344 — SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners · NA · not yet recruiting
NCT07526545 — Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial · NA · not yet recruiting
NCT07443943 — A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive · Phase 2 · recruiting
NCT07365007 — A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Ca · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04827459 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan Rogel Cancer Center
Last refreshed: 2 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04827459.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing